HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angioimmunoblastic lymphadenopathy in a patient taking diphenylhydantoin.

Abstract
The premise that chronic antigenic stimulation may be involved in lymphoproliferative disorders was considered in a patient with angioimmunoblastic lymphadenopathy who had received diphenylhydantoin (DPH) for seizure. This patient had clinical features overlapping with systemic lupus erythematosus (SLE) and serum antibody directed against DPH. It was proposed that the syndrome was caused by chronic antigenic stimulation with DPH.
AuthorsS H Tsung, J I Lin
JournalAnnals of clinical and laboratory science (Ann Clin Lab Sci) 1981 Nov-Dec Vol. 11 Issue 6 Pg. 542-5 ISSN: 0091-7370 [Print] United States
PMID6976773 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Antinuclear
  • Phenytoin
Topics
  • Aged
  • Antibodies, Antinuclear (analysis)
  • Female
  • Humans
  • Immunoblastic Lymphadenopathy (etiology, immunology, pathology)
  • Lymph Nodes (pathology)
  • Phenytoin (adverse effects, immunology, therapeutic use)
  • Seizures (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: